Defunct Company
Total Trials
36
As Lead Sponsor
34
As Collaborator
2
Total Enrollment
3,132
NCT00570141
OASIS Wound Matrix (Oasis) Mechanism of Action
Phase: Phase 4
Role: Lead Sponsor
Start: Oct 31, 2007
Completion: Apr 30, 2010
NCT00644917
Clinical Evaluation of the Phototoxic Potential of Xenaderm Ointment
Phase: Phase 1
Start: Feb 29, 2008
Completion: Feb 29, 2008
NCT00645164
Clinical Evaluation of the Photoallergy Potential of Xenaderm Ointment
Start: Mar 31, 2008
Completion: Jun 30, 2008
NCT00651820
Effect of Collagenase on Healing and Scarring
Start: Apr 30, 2008
Completion: Mar 31, 2010
NCT00713349
Controlled Study of the Effect of Xenaderm® Ointment Vehicle Versus White Petrolatum on Healing
Phase: Phase 2
Start: Jun 30, 2008
Completion: Sep 30, 2008
NCT00714519
Feasibility Study of the Execution of an Efficacy Trial in the Nursing Home Setting
Start: Jul 31, 2008
Completion: Oct 31, 2008
NCT00767455
Cumulative Irritation Potential of 828 Ointment
Start: Oct 31, 2008
Completion: Nov 30, 2008
NCT00767676
Contact Sensitization Potential of 828 Ointment
NCT00852995
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Start: Feb 28, 2009
Completion: Jul 31, 2011
NCT00900029
Safety Follow-Up to HP 802-247-09-015
Phase: N/A
Start: Jun 30, 2009
Completion: Jan 31, 2012
NCT00971048
Evaluation of the Effects of HP828-101 Versus Standard of Care in the Management of Partial or Full Thickness Wounds
Start: Sep 30, 2009
Completion: Jan 31, 2011
NCT01056198
Santyl vs. Sharp Debridement of Diabetic Foot Wounds
Start: Feb 28, 2010
Completion: Nov 30, 2011
NCT01108523
Evaluation of Effects of HP828-101 for Moisture Associated Skin Damage
Phase: Early Phase 1
Start: Apr 30, 2010
Completion: Feb 29, 2012
NCT01135290
Post Treatment Care After Chemical Peel or Laser Resurfacing
Start: Jun 30, 2010
Completion: Oct 31, 2010
NCT01143714
A Study to Look at the Effects of Four Weeks of Treatment on the Healing of Diabetic Foot Ulcers
Completion: Oct 31, 2012
NCT01208220
Effectiveness Study of Santyl Ointment to Treat Pressure Ulcers
Role: Collaborator
Completion: Dec 31, 2011
NCT01143727
Enzymatic Versus (vs) Autolytic Debridement of Diabetic Foot Ulcers
Start: Jul 31, 2010
NCT01190865
Study of Survival Duration for Donor Skin Cells in Skin Biopsy Wounds
Start: Sep 30, 2010
Completion: Dec 31, 2010
NCT01197898
Wound Edge Changes Following Treatment With Santyl
Start: Dec 31, 2010
NCT01253135
Study to Determine if Fibrin Affects the Ability of a Wound to Heal
Start: Jan 31, 2011
NCT01359735
Healing Effects of HP802-247 Versus Antibiotic Ointment in Mohs Micrographic Surgery Patients
Start: May 31, 2011
Completion: May 31, 2012
NCT01408277
Using Santyl on Diabetic Foot Ulcers
Start: Aug 31, 2011
Completion: Mar 31, 2013
NCT01433159
Comparison of HP011-101 to Standard Care for Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury
Start: Sep 30, 2011
Completion: Jan 31, 2013
NCT01668030
Comparison of Wound Bed Establishment in Facial Burns
Start: Feb 29, 2012
Completion: Aug 31, 2014
NCT01516463
Using Santyl or Bacitracin on Second Degree Burns
Start: Mar 31, 2012
Completion: Dec 31, 2013
NCT01528306
A Pilot Study of HP802-247 in Dystrophic Epidermolysis Bullosa
Completion: Jul 31, 2013
NCT01656889
Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers
Phase: Phase 3
Start: Aug 31, 2012
Completion: Dec 31, 2014
NCT01658618
Safety Study Providing 12 Months Follow-up From First Exposure to HP802-247 in Subjects With Venous Leg Ulcer
Start: Sep 30, 2012
Completion: May 31, 2015
NCT01705860
Long Term Follow Up to Determine the Effects of Collagenase SANTYL Ointment on Scar Formation
Completion: Apr 30, 2013
NCT01737762
Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2
Start: Nov 30, 2012
Completion: Nov 30, 2015
NCT01835379
Study of Oasis Ultra in Diabetic Foot Ulcers
Start: May 31, 2013
Completion: Sep 30, 2014
NCT01853384
Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers
Start: Nov 30, 2013
Completion: Feb 28, 2015
NCT02111291
Santyl Applications to Diabetic Foot Ulcers
Start: Apr 30, 2014
Completion: Dec 31, 2015
NCT01970657
Observational Study Providing 12 Months of Safety Follow-Up From First Exposure to HP802-247
Start: May 31, 2014
NCT02154087
A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers
Start: Jul 31, 2014
Completion: Oct 31, 2015